KIRKLAND, QC, Sept. 17, 2026 /CNW/ — Pfizer Canada ULC and BioNTech SE today announced that Health Canada has authorized the XFG variant-adapted COMIRNATY® for active immunization of individuals aged 6 months and older against COVID-19. The updated COMIRNATY® vaccine targets the Omicron XFG lineage, in alignment with public health recommendations for the 2026-2027 season.
The Health Canada approval is based on the cumulative body of evidence previously submitted by Pfizer and BioNTech that includes clinical, non-clinical and real-world data supporting the safety and effectiveness of COMIRNATY®.
Comments closed

